{"url":"https://whatshealthyandwhy.com/egcg/green-tea-catechin","path":"/egcg/green-tea-catechin","alternates":{"json":"https://whatshealthyandwhy.com/api/articles/egcg/green-tea-catechin.json","markdown":"https://whatshealthyandwhy.com/egcg/green-tea-catechin.md"},"topic":{"slug":"egcg","name":"EGCG","url":"https://whatshealthyandwhy.com/egcg"},"slug":"green-tea-catechin","order":1,"title":"EGCG: The Green Tea Catechin Behind Most of the Benefits","question":"Does EGCG from green tea protect your heart, and are supplements safe?","answer":"Drinking several cups of green tea a day likely lowers heart-disease and stroke deaths, but high-dose EGCG extracts can injure the liver.","description":"How epigallocatechin gallate from green tea works, what the human evidence actually shows, and why the dose and form matter for safety","confidence":3,"confidenceNote":"One cohort of 40,530 Japanese adults and a meta-analysis of 11 RCTs on weight; cancer trials were small (60 and 42 people).","evidenceSummary":{"rctCount":2,"observationalCount":1,"metaAnalysisCount":2,"totalParticipants":"40,000+","replicated":true,"newestStudyYear":2018},"category":{"categoryTitle":"What's Good For You","categorySlug":"good-for-you","subcategoryName":"Supplements & Vitamins","subcategorySlug":"supplements","url":"https://whatshealthyandwhy.com/explore/good-for-you/supplements"},"actions":["Drink 3–5 cups of brewed green tea daily, the intake linked to cardiovascular benefit in Japanese cohorts [5].","Prefer brewed tea to extracts: no liver injury has been linked to brewed tea, even at very high intake [4].","If you use an extract, take it with meals in divided doses and stay under 800 mg EGCG a day [4]."],"cautions":["Concentrated extracts above 800 mg EGCG/day, especially on an empty stomach, are linked to liver injury; avoid with liver disease [4].","Check with a doctor first if pregnant, on blood thinners, or taking bortezomib (EGCG can block its activity) [6]."],"simpleText":"EGCG (epigallocatechin gallate) is the most abundant and most studied catechin in green tea — and it's responsible for most of green tea's reputation as a health drink. It's a powerful polyphenol that scavenges free radicals, modulates inflammation, and interacts with several pathways involved in cancer growth, metabolism, and cardiovascular health [6]. Decades of research, from large Japanese population studies to randomized trials in cancer patients, suggest EGCG meaningfully contributes to longevity and disease prevention — though dose, form, and bioavailability matter a lot [5][1].","mediumText":"How EGCG Works\n\nEGCG is one of four major catechins in green tea, alongside EGC, ECG, and EC. It accounts for roughly 50–80% of total catechins in a typical green tea infusion. Chemically it's a flavan-3-ol with a galloyl group attached — that galloyl group is the part that makes EGCG unusually bioactive compared to its sister catechins.\n\nMultiple Mechanisms in Parallel\n\nEGCG doesn't act through a single pathway. Instead, it touches many systems at once, which is part of why its biological effects are broad but also hard to pin down clinically:\n\n- Direct antioxidant activity — EGCG's eight hydroxyl groups donate electrons to neutralize reactive oxygen species, sparing lipids, proteins, and DNA from oxidative damage\n- Nrf2 activation — like sulforaphane, EGCG triggers the body's master antioxidant defense system, indirectly upregulating endogenous enzymes such as glutathione peroxidase. See our Sulforaphane page for more on Nrf2\n- NF-κB suppression — dampens the master inflammatory transcription factor, reducing TNF-α, IL-6, and other inflammatory cytokines\n- 67-kDa laminin receptor binding — EGCG binds a specific cell-surface receptor that triggers anti-cancer signaling and may explain its selectivity for tumor cells\n- AMPK activation — switches cells into an energy-conserving, fat-burning mode similar to caloric restriction\n- DNA methylation modulation — EGCG inhibits DNA methyltransferase enzymes, an epigenetic effect that can reactivate silenced tumor suppressor genes\n\nBioavailability Is the Catch\n\nThe biggest practical problem with EGCG is that very little of what you swallow actually reaches your bloodstream. Plasma concentrations after a strong cup of green tea peak at only 0.1–0.3 µM — well below the 5–50 µM concentrations used in most cell culture studies that show dramatic effects. Bioavailability improves when EGCG is taken on an empty stomach (fasted absorption can be 3–5x higher than with food), and absolute amounts are higher with concentrated extracts than from brewed tea alone.\n\nPractical Use\n\nFrom green tea:\n- A typical 8 oz cup of brewed green tea contains 50–100 mg of EGCG\n- Matcha, where the whole leaf is consumed as powder, delivers roughly 2–3x more EGCG per serving\n- 3–5 cups daily approximates the intake associated with cardiovascular and cancer benefits in Japanese cohort studies [5]\n\nFrom supplements:\n- Standardized green tea extracts typically deliver 200–400 mg EGCG per capsule\n- Most clinical trials use 200–800 mg/day\n- Always take in divided doses with meals if taking >400 mg/day to reduce hepatotoxicity risk\n- Avoid empty-stomach dosing of high-dose extracts — this is where most reported liver injury cases have occurred [4]\n\nWho should be cautious:\n- Anyone with liver disease or on hepatotoxic medications\n- People taking the chemotherapy drug bortezomib (Velcade) — EGCG can block its activity\n- Pregnant women — EGCG can interfere with folate metabolism\n- People on blood thinners — EGCG has mild anti-platelet effects","deepText":"Evidence Review\n\nProstate Cancer Chemoprevention (Bettuzzi et al., 2006)\n\nThis Italian proof-of-principle study, published in Cancer Research [PMID 16424063], remains one of the most striking pieces of human evidence for EGCG. Sixty men with high-grade prostatic intraepithelial neoplasia (HGPIN) — a pre-cancerous lesion that progresses to prostate cancer in roughly 30% of men within a year — were randomized to either 600 mg/day of green tea catechins (containing roughly 300 mg EGCG) or placebo for 12 months.\n\nKey findings:\n- Prostate cancer incidence: 1 of 30 (3%) in the catechin group vs 9 of 30 (30%) in the placebo group\n- PSA values: stable in the catechin group, rising in the placebo group\n- Adverse events: none significantly different from placebo\n- Quality-of-life scores related to lower urinary tract symptoms also improved in the catechin group\n\nThe 90% relative risk reduction is unusually large for a chemopreventive intervention. The trial was small and a single-center study, so it should not be taken as definitive — but it remains a foundational signal that EGCG-containing extracts have meaningful anti-cancer activity in humans, not just in test tubes.\n\nPolyphenon E in Chronic Lymphocytic Leukemia (Shanafelt et al., 2013)\n\nThis Mayo Clinic Phase 2 trial, published in Cancer [2], evaluated oral Polyphenon E (a standardized green tea extract) at a dose delivering 2,000 mg of EGCG, taken twice daily for up to 6 months, in 42 previously untreated patients with early-stage, asymptomatic chronic lymphocytic leukemia (CLL).\n\nKey findings:\n- Lymphocyte response: a sustained reduction of at least 20% in the absolute lymphocyte count in 13 of 42 patients (31%)\n- Lymph node response: at least a 50% reduction in the sum of the products of all lymph node areas in 20 of the 29 patients (69%) who had palpable lymph nodes\n- Overall biologic response: 29 patients (69%) met the criteria for a biologic response (a sustained fall of at least 20% in lymphocyte count and/or at least 30% in lymph node size) at some point during the 6 months\n- Tolerability: generally well tolerated; the most common grade 3 side effects were transaminitis, abdominal pain, and fatigue, in one patient each\n\nThis trial, which followed an earlier Phase 1 dose-finding study, suggests that high-dose EGCG can produce measurable biological responses in patients with early-stage CLL. It had no placebo group, and the dose used (4,000 mg of EGCG per day) is far above what tea or typical supplements provide.\n\nWeight Loss Meta-Analysis (Hursel, Viechtbauer, and Westerterp-Plantenga, 2009)\n\nHursel R and colleagues published a meta-analysis in the International Journal of Obesity [3] of 11 studies of green tea catechins for weight loss and weight maintenance.\n\nKey findings:\n- Weight loss and maintenance: catechins significantly decreased body weight and helped maintain weight after a period of weight loss, by about 1.31 kg on average compared with controls (P<0.001)\n- Caffeine may matter: the effect was −1.60 kg in people with low habitual caffeine intake and −0.27 kg in those with high intake (above 300 mg per day), but this difference did not reach statistical significance (P = 0.09)\n- Ethnicity may matter: the effect was −1.51 kg in Asian and −0.82 kg in Caucasian participants, also not statistically significant (P = 0.37), although the interaction of ethnicity and caffeine intake was a significant moderator (P = 0.04)\n\nThe authors concluded that catechins, or an EGCG-caffeine mixture, have a small positive effect on weight loss and weight maintenance. The clinical takeaway is that EGCG produces a real but small weight-loss effect — useful as part of a broader strategy, not as a standalone intervention.\n\nPopulation-Level Mortality Data: The Ohsaki Study (Kuriyama et al., 2006)\n\nPublished in JAMA [PMID 16968850], this prospective cohort study followed 40,530 Japanese adults aged 40–79 for up to 11 years, tracking green tea consumption against all-cause and disease-specific mortality.\n\nKey findings:\n- All-cause mortality: participants drinking ≥5 cups/day vs <1 cup/day had hazard ratios of 0.84 in women and 0.88 in men\n- Cardiovascular mortality: even larger reductions, with hazard ratios as low as 0.69 for women drinking ≥5 cups/day\n- Stroke mortality specifically: the largest single contributor to the cardiovascular benefit\n- Cancer mortality: no significant association in this cohort, despite mechanistic expectations\n\nThe dose pattern — clear cardiovascular benefit, modest all-cause benefit, no cancer mortality signal — is broadly consistent with what later meta-analyses found across multiple cohorts. EGCG and other tea catechins are best supported for cardiovascular protection at the population level.\n\nSafety: When EGCG Hurts the Liver (Hu, Webster, Cao, and Shao, 2018)\n\nPublished in Regulatory Toxicology and Pharmacology [PMID 29580974], this systematic review pooled human safety data from clinical trials and case reports of green tea extracts. The most clinically relevant findings:\n\n- Hepatotoxicity threshold: liver injury cases cluster at intakes above 800 mg EGCG/day from concentrated supplements, particularly when taken on an empty stomach\n- Mechanism: likely a combination of direct hepatocyte oxidative stress at high concentrations and idiosyncratic immune-mediated reactions in genetically susceptible individuals (HLA-B*35:01 has been implicated)\n- Brewed tea is largely safe: no liver injury cases linked to even very high consumption of brewed green tea — the issue is with concentrated extract supplements\n- Recommended upper limit: the European Food Safety Authority set a tolerable upper limit of 800 mg EGCG/day from supplements, with cautions about empty-stomach dosing …","deepTruncated":true,"references":[{"id":"1","title":"Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study","authors":"Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A","year":2006,"journal":"Cancer Research","pmid":"16424063","url":"https://pubmed.ncbi.nlm.nih.gov/16424063/"},{"id":"2","title":"Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia","authors":"Shanafelt TD, Call TG, Zent CS, Leis JF, LaPlant B, Bowen DA, Roos M, Laumann K, Ghosh AK, Lesnick C, Lee MJ, Yang CS, Jelinek DF, Erlichman C, Kay NE","year":2013,"journal":"Cancer","pmid":"22760587","url":"https://pubmed.ncbi.nlm.nih.gov/22760587/"},{"id":"3","title":"The effects of green tea on weight loss and weight maintenance: a meta-analysis","authors":"Hursel R, Viechtbauer W, Westerterp-Plantenga MS","year":2009,"journal":"International Journal of Obesity","pmid":"19597519","url":"https://pubmed.ncbi.nlm.nih.gov/19597519/"},{"id":"4","title":"The safety of green tea and green tea extract consumption in adults - Results of a systematic review","authors":"Hu J, Webster D, Cao J, Shao A","year":2018,"journal":"Regulatory Toxicology and Pharmacology","pmid":"29580974","url":"https://pubmed.ncbi.nlm.nih.gov/29580974/"},{"id":"5","title":"Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study","authors":"Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I","year":2006,"journal":"JAMA","pmid":"16968850","url":"https://pubmed.ncbi.nlm.nih.gov/16968850/"},{"id":"6","title":"Tea Polyphenols in Promotion of Human Health","authors":"Khan N, Mukhtar H","year":2018,"journal":"Nutrients","pmid":"30585192","url":"https://pubmed.ncbi.nlm.nih.gov/30585192/"}],"wordCount":1684,"source":{"path":"src/content/topics/egcg/green-tea-catechin.md"},"citeAs":"“Does EGCG from green tea protect your heart, and are supplements safe?.” What's Healthy and Why. https://whatshealthyandwhy.com/egcg/green-tea-catechin","notice":"General information backed by peer-reviewed research, not medical advice."}